← Evidence map

ReviewPharmaceutical research2016

Targeting Nanomedicines to Prostate Cancer: Evaluation of Specificity of Ligands to Two Different Receptors In Vivo.

Amanda K Pearce et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2016

2017

2018

2019

2020

this papercites it

Targeting Nanomedicines to Prostate Cancer: Evaluation of Specificity of Ligands to Two Different Receptors In Vivo. | OpenQuestion